The relationship between serum uric acid and spirometric values in participants in a health check: The takahata study

International Journal of Medical Sciences

Volumn 8, Issue 6, 2011, Pages 470-478

  Aida, Yasuko ^a   Shibata, Yoko ^a   Osaka, Daisuke ^a   Abe, Shuichi ^a   Inoue, Sumito ^a   Fukuzaki, Koji ^a   Tokairin, Yoshikane ^a   Igarashi, Akira ^a   Yamauchi, Keiko ^a   Nemoto, Takako ^a   Nunomiya, Keiko ^a   Kishi, Hiroyuki ^a   Sato, Masamichi ^a   Watanabe, Tetsu ^a   Konta, Tsuneo ^a   Kawata, Sumio ^b   Kato, Takeo ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Epidemiology; Pulmonary function; Spirometry; Uric acid

Indexed keywords

ALCOHOL; HEMOGLOBIN A1C; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MALE; RESPIRATORY AIRFLOW; SPIROMETRY; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

EID: 80052047547     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.470     Document Type: Article

References (43)

1. [Internet] Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/
2. Osaka D, Shibata Y, Abe S, et al. Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: The Takahata Study. Intern Med, 2010; 49: 1489-1499.
3. Mentzer RM Jr, Rubio R, Berne RM. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol, 1975; 229: 1625-1631.
4. Woolliscroft JO, Colfer H, Fox IH. Hyperuricemia in acute illness: A poor prognostic sign. Am J Med, 1982; 72: 58-62.
5. Elsayed NM, Nakashima JM, Postlethwait EM. Measurement of uric acid as a marker of oxygen tension in the lung. Arch Bio-chem Biophys, 1993; 302: 228-232.
6. Garcia-Pachon E, Padilla-Navas I, Shum C. Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease. Lung, 2007; 185: 21-24.
7. Saito H, Nishimura M, Shibuya E, et al. Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest, 2002; 122: 1686-1694.
8. Shimizu Y, Nagaya N, Satoh T, et al. Serum uric acid level increases in proportion to the severity of pulmonary throm-boembolism. Circ J, 2002; 66: 571-575.
9. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperu-ricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 2004; 4: 9.
10. Nan H, Qiao Q, Soderberg S, et al. Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. Metab Syndr Relat Disord, 2008; 6: 47-57.
11. Rathmann W, Haastert B, Icks A, et al. Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: The cardia study. Eur J Epidemiol, 2007; 22: 439-445.
12. Garcia-Larsen V, Chinn S, Rodrigo R, et al. Relationship between oxidative stress-related biomarkers and antioxidant status with asthma and atopy in young adults: A population-based study. Clin Exp Allergy, 2009; 39: 379-386.
13. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: The Takahata Study. Kidney Int, 2006; 70: 751-756.
14. The Committee of Pulmonary Physiology JRS. Guidelines for pulmonary function tests: Spirometry, flow-volume curve, diffusion capacity of the lung. Tokyo, 2004.
15. Zheng L, Sun Z, Li J, et al. Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China. Stroke, 2008; 39: 1932-1937.
16. So A, Thorens B. Uric acid transport and disease. J Clin Invest, 2010; 120: 1791-1799.
17. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: The third national health and nutrition examination survey. Arthritis Rheum, 2005; 52: 283-289.
18. Choi HK, Curhan G. Beer, liquor, and wine consumption and serum uric acid level: The third national health and nutrition examination survey. Arthritis Rheum, 2004; 51: 1023-1029.
19. Feig DI. Uric acid: A novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens, 2009; 18: 526-530.
20. Nyhan WL. Lesch-Nyhan disease. J Hist Neurosci, 2005; 14: 1-10.
21. Cameron JS, Moro F, Simmonds HA. Gout, uric acid and purine metabolism in paediatric nephrology. Pediatr Nephrol, 1993; 7: 105-118.
22. McCord JM, Roy RS, Schaffer SW. Free radicals and myocardial ischemia. The role of xanthine oxidase. Adv Myocardiol, 1985; 5: 183-189.
23. Sjodin B, Hellsten Westing Y, Apple FS. Biochemical mechanisms for oxygen free radical formation during exercise. Sports Med, 1990; 10: 236-254.
24. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging. Circulation, 2003; 107: 1991-1997.
25. Holme I, Aastveit AH, Hammar N, et al. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the apolipoprotein mortality risk study (AMORIS). J Intern Med, 2009; 266: 558-570.
26. Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol, 2008; 19: 2407-2413.
27. Sato N, Kurashima K, Ubukata M, et al. [Prognostic significance of serum uric acid in patients with chronic obstructive pulmonary disease receiving home oxygen therapy]. Nihon Kokyuki Gakkai Zasshi, 2003; 41: 74-80.
28. Ruggiero C, Cherubini A, Miller E 3rd, et al. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol, 2007; 100: 115-121.
29. Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 2006; 440: 237-241.
30. Becker BF, Reinholz N, Leipert B, et al. Role of uric acid as an endogenous radical scavenger and antioxidant. Chest, 1991; 100: 176S-181S.
31. Kirschvink N, Fievez L, Bureau F, et al. Adaptation to multiday ozone exposure is associated with a sustained increase of bronchoalveolar uric acid. Free Radic Res, 2002; 36: 23-32.
32. Cross CE, van der Vliet A, O'Neill CA, et al. Oxidants, antioxi-dants, and respiratory tract lining fluids. Environ Health Per-spect, 1994; 102 (Suppl 10): 185-191.
33. Sperling O. Hereditary renal hypouricemia. Mol Genet Metab, 2006; 89: 14-18.
34. Kaneko K, Taniguchi N, Tanabe Y, et al. Oxidative imbalance in idiopathic renal hypouricemia. Pediatr Nephrol, 2009; 24: 869-871.
35. Tanaka M, Itoh K, Matsushita K, et al. Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis, 2003; 42: 1287-1292.
36. Ryu JH, Krowka MJ, Pellikka PA, et al. Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc, 2007; 82: 342-350.
37. Voelkel MA, Wynne KM, Badesch DB, et al. Hyperuricemia in severe pulmonary hypertension. Chest, 2000; 117: 19-24.
38. Didilescu AC, Hanganu SC, Galie N, et al. [The role of smoking in changing essential parameters in body homeostasis]. Pneu-mologia, 2009; 58: 89-94.
39. El-Agha O, Gokmen IG. Smoking habits and cadmium intake in Turkey. Biol Trace Elem Res, 2002; 88: 31-43.
40. Rahman I, MacNee W. Role of oxidants/antioxidants in smok-ing-induced lung diseases. Free Radic Biol Med, 1996; 21: 669-681.
41. Jeha S. Tumor lysis syndrome. Semin Hematol, 2001; 38: 4-8.
42. Arao T, Takabatake N, Sata M, et al. In vivo evidence of endo-thelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med, 2003; 44: 1747-1754.
43. Tuder RM, Zhen L, Cho CY, et al. Oxidative stress and apopto-sis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol, 2003; 29: 88-97.